Facebook
Twitter
LinkedIn
ForwardBreast
This educational activity will focus on the radiation therapy treatment scenarios commonly faced in breast cancer practice; i.e., breast radiation for early stage disease undergoing breast conservation and regional nodal irradiation for node positive breast cancer. Breast radiation following lumpectomy for ductal carcinoma in situ and early invasive breast cancer including whole breast irradiation ; partial breast irradiation and observation, as well as the clinical trial data supporting treatment effectiveness, will be reviewed. This educational activity will also focus on the evidence, indications and methodology for regional nodal irradiation post mastectomy or lumpectomy in breast cancer patients with 1-3 axillary nodal metastasis in the setting of adjuvant systemic therapy. Regional nodal irradiation in the post neoadjuvant systemic therapy setting will be reviewed as well.
Target Audience
The meeting is designed to meet the interests of practicing radiation oncologists, radiation oncology residents, medical and clinical physicists, nurses and all other health professionals involved in the field of radiation oncology.
Learning Objectives
Upon completion of this activity, participants should be able to do the following:
- Identify current optimal radiation methods and suitable patient populations for breast conserving treatment in early stage invasive and non-invasive breast cancer.
- Describe rationale and indications for regional nodal irradiation post mastectomy and lumpectomy for node positive breast cancer in the setting of adjuvant and neoadjuvant systemic therapy
- Recognize radiation methods that maximize the therapeutic ratio by minimizing toxicity from breast conserving therapy in early stage disease and regional nodal irradiation in node positive disease.
Julia White, MD, FASTRO is employed by The Ohio State University and has no financial relationships with a commercial interest.
All relevant relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.
ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.
Available Credit
- 1.50 AMA PRA Category 1 Credit™The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.50 Certificate of AttendanceThis activity was designated for 1.50 AMA PRA Category 1 Credit™.